Business
Vaccine safety experts from the World Health Organization (WHO) are meeting on Tuesday to review the Oxford-AstraZeneca jab, after several European countries halted their roll-outs. About 17 million people in the EU and the UK have received a dose of the vaccine, with fewer than 40 cases of blood clots reported as of last week, AstraZeneca said.